Manuel Mohr
Company: D2B3
Job title: Co-Founder & Chief Executive Officer
Seminars:
Workshop B: Advancing Gene Therapy to Treat Alzheimer’s & Parkinson’s Disorders 10:30 am
As the last couple of years have welcomed approved neurological gene therapies from Bluebird Bio, PTC Therapeutics, Novartis, Sarepta Therapeutics, what is the route forward for gene therapy development for Alzheimer’s & Parkinson’s disease? This workshop explores the most recent developments in gene therapy, including brain delivery, preclinical models, translation of gene therapy research into…Read more
day: Pre-Conference Workshop Day